Korean player Daesang moves on EU omega-3 market

- Last updated on GMT

Korean player Daesang  moves on EU omega-3 market

Related tags: Nutrition

Korean food giant Daeseng wants to enter the EU omega-3 market and has applied for novel foods approval for an algae-derived DHA (docosahexaenoic acid).

The application​seeks ‘substantial equivalence’ with DSM-Martek’s Schizochytrium​-derived DHA that was approved for use in the European Union food supply in 2003.

“Taken together, given the fact that the DHA content of Daesang DHA-rich oil is in compliance with the authorised product specifications (CID 2014/463/EU) and given the relatively minor differences in percentage for some of the other fatty acids, we consider the fatty acid profiles of our DHA-rich oil to be substantially equivalent to DSM/Martek DHA-rich oil,” ​the firm said in its application to the UK Food Standards Agency (FSA).

Schizochytrium​-derived DHA is approved for use in a wide variety of formats across the EU including dairy products, cereals, food supplements and medical foods.

Daesang manufactures a range of foodstuffs including margarine, coffee and pasta and has a suite of ingredients including starch, chrolella and algae.

There are nine DHA-related approved health claims​ in the European Union relating to brain health, heart health and vision in adults and infants and foetuses. Some of the claims are in conjunction with omega-3 form EPA (eicosapentaenoic acid).

Daeseng-dha-table

Daeseng-DHAuses

Related news

Related product

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast